NIH PAS · NIDA · R03
PAS-27-028: Science Track Award for Research Transition (START) Program (R03, Clinical Trial Optional)
Reviewed by Dr. Meng ZhaoLast reviewed October 16, 2026Data refreshed October 16, 2026Editorial standards
The purpose of this notice of funding opportunity (NOFO) is to facilitate the entry of investigators into multiple high-priority areas of substance use research, including comorbidity with HIV. The Science Track Award for Research Transition (START) Program aims to provide investigators with the opportunity to gather preliminary data that will assist them in securing future research grants and advancing their scientific careers.
- NOFO number
- PAS-27-028
- Type
- PAS
- Activity code
- R03
- Primary institute
- NIDA · National Institute on Drug Abuse
- Clinical trials
- Optional
- Posted
- Jun 9, 2026
- Opens
- Sep 16, 2026
- Expires
- Mar 17, 2029
PAS-27-028 due dates
8 application due dates remain before the NOFO expires. Dates marked * are NIH standard due dates. Check the related notices below for changes NIH made after posting.
| New | Renewal / Resubmission / Revision (as allowed) | AIDS - New/Renewal/Resubmission/Revision, as allowed | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
|---|---|---|---|---|---|
| October 16, 2026 * | November 16, 2026 * | Not Applicable | March 2027 | May 2027 | July 2027 |
| February 16, 2027 * | March 16, 2027 * | Not Applicable | July 2027 | October 2027 | December 2027 |
| June 16, 2027 * | July 16, 2027 * | Not Applicable | November 2027 | January 2028 | April 2028 |
| October 16, 2027 * | November 16, 2027 * | Not Applicable | March 2028 | May 2028 | July 2028 |
| February 16, 2028 * | March 16, 2028 * | Not Applicable | July 2028 | October 2028 | December 2028 |
| June 16, 2028 * | July 16, 2028 * | Not Applicable | November 2028 | January 2029 | April 2029 |
| October 16, 2028 * | November 16, 2028 * | Not Applicable | March 2029 | May 2029 | July 2029 |
| February 16, 2029 * | March 16, 2029 * | Not Applicable | July 2029 | October 2029 | December 2029 |
What its predecessor PAR-24-297 funded
PAS-27-028 reissues PAR-24-297. Until awards appear under the new number, its funding history is the best guide to who wins under this program: 2 projects and $470K in FY2022–FY2026.
Projects funded
2
Distinct projects, FY2022–FY2026
New awards
2
Type 1 (new project) award records
NIH funding
$470K
Award dollars under PAR-24-297, FY2022–FY2026
Funding by fiscal year
| Fiscal year | Award records | New awards | Funding |
|---|---|---|---|
| FY2022 | 0 | 0 | $0 |
| FY2023 | 0 | 0 | $0 |
| FY2024 | 0 | 0 | $0 |
| FY2025 | 0 | 0 | $0 |
| FY2026 | 2 | 2 | $470K |
Institutions with the most funding
- University of California, San Diego$239K · 1 project
- Univ of North Carolina Chapel Hill$230K · 1 project
Funding institutes
- NIDA$470K · 2
Activity codes funded
- R032 records
Most recent new awards
- The effect of genetic background on functional brain networks activated in response to cocaine using whole brain imaging (opens NIH RePORTER)
Univ of North Carolina Chapel Hill · 1R03DA062846-01A1 · NIDA · Notice May 18, 2026
$230KR03
- Longitudinal Multiparametric Magnetic Resonance Imaging of Outbred Rats with Variable Vulnerability to the Development of Oxycodone Addiction-like Behaviors (opens NIH RePORTER)
University of California, San Diego · 1R03DA064666-01 · NIDA · Notice Feb 20, 2026
$239KR03
FY2026 closed on September 30, 2026, but NIH keeps posting that year's awards to RePORTER for several weeks. FY2026 figures reflect records available on October 16, 2026 and may rise slightly at the next refresh.
Participating institutes
2 NIH institutes and offices take applications under PAS-27-028. Contact the program officer at the institute that fits your research before applying.
- NIDA · National Institute on Drug Abuse
- none
Related notices
NIH lists no related notices for PAS-27-028 yet.
Award terms
- Application types allowed
- New Resubmission The OER Glossary and the How to Apply Application Guide provide details on these application types. Only those application types listed here are allowed for this NOFO.
- Award budget
- Budgets for direct costs of up to 100,000 per year for up to 2 years, may be requested.
- Project period
- The maximum project period is 2 years. NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this NOFO.
- Funds available and number of awards
- NIDA intends to fund an estimate of six to seven awards per fiscal year, corresponding to a total of 1,000,000 per fiscal year for the fiscal years of 2027, 2028, 2029, and 2030. The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Summarized from the NOFO text; the full NOFO governs eligibility, budget, and review.
Related NOFOs
- Reissue of PAR-24-297.
Other open NOFOs for R03
- PAR-25-370Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)NHGRI · next due Oct 16, 2026
- PA-25-302NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)NIH · next due Oct 16, 2026
- PAR-25-233Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)NCI · next due Oct 16, 2026
- PAR-27-074Limited Competition: Small Grant Program for Mentored Research Career Development Award Recipients (R03) (Clinical Trials Not Allowed)NIAMS · next due Oct 16, 2026
- PAR-25-091Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)NIDDK · next due Oct 16, 2026
- PA-25-125NICHD Small Research Grant Program (R03 Clinical Trial Required)NICHD · next due Oct 16, 2026
About this page
GotGrant gathers the NOFO, its participation and change notices, and its NOSIs from the NIH Guide for Grants and Contracts, and counts funded projects from NIH RePORTER by the opportunity number each award was made under. Data refreshed October 16, 2026; the NIH Guide is the authoritative source. See our data methodology.